Resources

Selected
  • Systematic reviews (SYSVAC)
  • Pregnant women
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date
264 results found
2026 ∙ Lister, H. Farquharson, K. Seale, H. Smith, L. E. Poletti, T. Amin, F. Rubin, G. J.
A systematic review of the impact of vaccine reactogenicity on willingness to accept influenza vaccination in adults
Adults Older adults Healthcare workers Pregnant women Influenza Acceptance Coverage
Methodological quality (AMSTAR 2):
Not applicable
2026 ∙ Rizzo, M. Tubassum, R. Kaplan, C. A. Konde, M. Martin, L. Gigase, F. de Witte, L. Bergink, V. Rommel, A. S.
Systematic Review and Meta-Analysis: The Associations of Prenatal Exposure to SARS-CoV-2 Infection and COVID-19 Vaccination With Child Neurodevelopment
Pregnant women COVID-19 Safety
Methodological quality (AMSTAR 2):
Moderate
2025 ∙ Saad, R. K. Khader, Y. Munoz, F. M. Lami, F. Mohsni, E. Haddad, N.
Burden of pertussis in infants in the Eastern Mediterranean Region and the impact of maternal vaccination: a systematic review
Eastern Mediterranean Pregnant women Pertussis Coverage
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Kong, F. Cai, L. Zhang, J. Zhu, H. Peng, Z. Zheng, J. Zheng, Y. Fang, H.
Comparative Analysis of Health Economic Evaluations for Different Influenza Vaccines and Vaccination Strategies in China: A Systematic Review
Western Pacific China All age groups Pregnant women Influenza Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Samal, J. Preetha, G. S. Kumar, R. P. Lakshman, N. Dehury, R. K. Singh, H.
Coronavirus Disease 2019 Vaccine Hesitancy and Acceptance among the Indian Population: A Systematic Review and Meta-Analysis
South-East Asia India Adolescents Adults Older adults Healthcare workers Parents/caregivers Pregnant women COVID-19 Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Shi, Q. Li, J. Hu, Q. Cheng, C. Yang, K. Li, X. Song, X. Chen, S. Duan, G.
Efficacy, Immunogenicity, and Safety of Pertussis Vaccine During Pregnancy: A Meta-Analysis
Pregnant women Pertussis Efficacy/effectiveness Safety
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Wang, Y. Zhang, Y. Wang, J. Shi, N. Jin, H.
Enhancing influenza vaccination uptake: a systematic review and meta-analysis of intervention strategies
All age groups Pregnant women Healthcare workers Influenza Coverage
Methodological quality (AMSTAR 2):
Not applicable
2025 ∙ Alandijany, T. A. Qashqari, F. S.
Evaluating the efficacy, safety, and immunogenicity of FDA-approved RSV vaccines: a systematic review of Arexvy, Abrysvo, and mResvia
All age groups Pregnant women RSV (Respiratory syncytial virus) Efficacy/effectiveness Safety Administration
Methodological quality (AMSTAR 2):
Low
2025 ∙ Nembot Fogang, B. A. Debrah, L. B. Owusu, M. Agyei, G. Meyer, J. Gmanyami, J. M. Ritter, M. Arndts, K. Adu Mensah, D. Adjobimey, T. Horauf, A. Debrah, A. Y.
Helminth Coinfections Modulate Disease Dynamics and Vaccination Success in the Era of Emerging Infectious Diseases
Children Adolescents Adults Pregnant women Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2025 ∙ Bergman, H. Henschke, N. Arevalo-Rodriguez, I. Buckley, B. S. Crosbie, E. J. Davies, J. C. Dwan, K. Golder, S. P. Loke, Y. K. Probyn, K. et al.,
Human papillomavirus (HPV) vaccination for the prevention of cervical cancer and other HPV‐related diseases: a network meta‐analysis
All age groups Pregnant women Human papillomavirus (HPV) Efficacy/effectiveness Safety Administration
Methodological quality (AMSTAR 2):
High
Loading...